IN2014DN07326A - - Google Patents

Info

Publication number
IN2014DN07326A
IN2014DN07326A IN7326DEN2014A IN2014DN07326A IN 2014DN07326 A IN2014DN07326 A IN 2014DN07326A IN 7326DEN2014 A IN7326DEN2014 A IN 7326DEN2014A IN 2014DN07326 A IN2014DN07326 A IN 2014DN07326A
Authority
IN
India
Prior art keywords
total
citrate
present
invention concerns
magnesium
Prior art date
Application number
Other languages
English (en)
Inventor
Anders Nilsson
Jan Sternby
Anders Wieslander
Original Assignee
Gambro Lundia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gambro Lundia Ab filed Critical Gambro Lundia Ab
Publication of IN2014DN07326A publication Critical patent/IN2014DN07326A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • External Artificial Organs (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN7326DEN2014 2012-03-08 2013-03-05 IN2014DN07326A (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE1250217A SE536913C2 (sv) 2012-03-08 2012-03-08 Komposition för dialys
US201261608660P 2012-03-09 2012-03-09
PCT/EP2013/054386 WO2013131906A1 (fr) 2012-03-08 2013-03-05 Composition de dialyse comprenant du citrate, du calcium et du magnésium

Publications (1)

Publication Number Publication Date
IN2014DN07326A true IN2014DN07326A (fr) 2015-04-24

Family

ID=49115964

Family Applications (1)

Application Number Title Priority Date Filing Date
IN7326DEN2014 IN2014DN07326A (fr) 2012-03-08 2013-03-05

Country Status (10)

Country Link
US (2) US9452149B2 (fr)
EP (2) EP2822549B1 (fr)
JP (1) JP6125545B2 (fr)
KR (1) KR102062932B1 (fr)
CN (1) CN104159579B (fr)
AU (1) AU2013201615B2 (fr)
CA (1) CA2865315C (fr)
IN (1) IN2014DN07326A (fr)
SE (1) SE536913C2 (fr)
WO (1) WO2013131906A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012129501A2 (fr) 2011-03-23 2012-09-27 Nxstage Medical, Inc. Systèmes de dialyse péritonéale, dispositif et méthodes
US9861733B2 (en) 2012-03-23 2018-01-09 Nxstage Medical Inc. Peritoneal dialysis systems, devices, and methods
SE536913C2 (sv) * 2012-03-08 2014-10-28 Gambro Lundia Ab Komposition för dialys
CA3212759A1 (fr) 2012-04-30 2013-11-07 Biocon Limited Proteines de fusion ciblees/immunomodulatrices et leurs procedes de fabrication
EP2826476B1 (fr) * 2013-07-16 2021-03-03 G.M.T. de Jong B.V. Fluide de dialyse exempt de calcium
AU2019228526B2 (en) 2018-02-28 2021-11-25 Nxstage Medical, Inc. Fluid preparation and treatment devices, methods, and systems

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3560380A (en) 1968-10-28 1971-02-02 Mallinckrodt Chemical Works Dry concentrates for preparing hemodialysis solutions
US4756838A (en) 1980-02-21 1988-07-12 Veltman Preston Leonard Preparation of dry dialysate products
EP0140929B1 (fr) 1983-04-13 1989-02-01 Field Group Chemicals Pty. Limited Sac de lavement
US4616671A (en) 1984-01-27 1986-10-14 Trw Inc. Valve with flow force compensator
DE3707190A1 (de) 1987-03-06 1988-09-22 Pav Praezisions Apparatebau Ag Messkluppe
JP2749375B2 (ja) 1989-05-26 1998-05-13 テルモ 株式会社 血液透析用製剤およびその製造方法
AU627309B2 (en) 1989-05-26 1992-08-20 Terumo Kabushiki Kaisha Preparation for blood dialysis and method for production thereof
US5071558A (en) 1989-08-11 1991-12-10 Nikkiso Co., Ltd. Sodium bicarbonate dialysate
JP2948315B2 (ja) 1990-12-18 1999-09-13 ザ ボード オブ リージェンツ オブ ザ ユニヴァーシティ オブ ワシントン 透析物ペレットを有する透析物生成システム
JPH04257522A (ja) 1991-02-07 1992-09-11 Nikkiso Co Ltd 重曹透析用剤
JP2769592B2 (ja) 1992-12-14 1998-06-25 富田製薬株式会社 重炭酸透析用人工腎臓灌流用剤の製造方法及び人工腎臓灌流用剤
JP3619921B2 (ja) 1996-09-13 2005-02-16 富田製薬株式会社 重炭酸固形透析用剤
FR2766797B1 (fr) 1997-07-30 1999-09-17 Smad Conditionnement pour au moins une matiere solide, notamment sous forme granuleuse ou pulverulente
US7670491B2 (en) 1998-10-20 2010-03-02 Advanced Renal Technologies Buffered compositions for dialysis
US6610206B1 (en) 1998-10-20 2003-08-26 Advanced Renal Technologies Buffered compositions for dialysis
US6274103B1 (en) 1999-03-26 2001-08-14 Prismedical Corporation Apparatus and method for preparation of a peritoneal dialysis solution
SE9901165D0 (sv) 1999-03-30 1999-03-30 Gambro Lundia Ab Method, apparatus and components of dialysis systems
US6489301B1 (en) 1999-06-07 2002-12-03 Nipro Corporation Solid pharmaceutical preparation for dialysis and a process for producing the same
CA2422850C (fr) * 1999-09-22 2009-03-03 Advanced Renal Technologies Dialysat a forte teneur en citrate et utilisation de celui-ci
DE19955578C1 (de) 1999-11-18 2001-09-06 Fresenius Medical Care De Gmbh Mehrkammerbehälter, mit Glucosekonzentratkompartiment und Salzsäurekonzentratkompartiment
JP3899506B2 (ja) 2000-09-27 2007-03-28 ニプロ株式会社 固形透析用製剤およびその製造方法
JP5204359B2 (ja) 2001-09-28 2013-06-05 味の素株式会社 透析用剤およびその製造方法
SE525132C2 (sv) 2001-11-23 2004-12-07 Gambro Lundia Ab Metod vid manövrering av dialysanordning
US7238164B2 (en) 2002-07-19 2007-07-03 Baxter International Inc. Systems, methods and apparatuses for pumping cassette-based therapies
JP4328851B2 (ja) 2003-03-03 2009-09-09 富田製薬株式会社 重炭酸固形透析剤
JP4647953B2 (ja) * 2003-12-26 2011-03-09 マナック株式会社 一剤型重炭酸透析用固形剤及びその製造方法
KR20060129363A (ko) 2004-02-09 2006-12-15 니프로 가부시키가이샤 투석용 고형제제 및 그 제조방법
JPWO2005094918A1 (ja) * 2004-03-30 2008-02-14 ニプロ株式会社 透析用固形製剤
CN1938058A (zh) 2004-03-30 2007-03-28 尼普洛株式会社 透析用固体制剂
MXPA06014608A (es) 2004-06-17 2007-06-12 Stora Enso North America Corp Materiales de empaque de alta proteccion con capas multiples.
US7544301B2 (en) 2004-08-19 2009-06-09 Hhd Llc Citrate-based dialysate chemical formulations
WO2006073164A1 (fr) 2005-01-07 2006-07-13 Ajinomoto Co., Inc. Preparation pour dialyse
RU2311202C1 (ru) 2006-02-08 2007-11-27 Общество С Ограниченной Ответственностью "Нпо "Нефрон" Способ получения кислотного компонента для бикарбонатного гемодиализа
US8133194B2 (en) 2006-02-22 2012-03-13 Henry Ford Health System System and method for delivery of regional citrate anticoagulation to extracorporeal blood circuits
CN105640930A (zh) 2006-12-12 2016-06-08 味之素株式会社 铁代谢改善剂
TWI419683B (zh) 2007-03-14 2013-12-21 Ajinomoto Kk 骨代謝改善劑
TWI516284B (zh) 2007-05-31 2016-01-11 味之素股份有限公司 透析用固態製劑
WO2010055963A1 (fr) 2008-11-17 2010-05-20 Lee, Jin Tae Procédé de fabrication d'une composition de dialysat exempt d'acétate
WO2010112570A1 (fr) * 2009-03-31 2010-10-07 Gambro Lundia Ab Solution de dialyse
WO2010112547A1 (fr) * 2009-03-31 2010-10-07 Gambro Lundia Ab Composition précurseur de dialyse
JP5752791B2 (ja) * 2010-06-23 2015-07-22 ガンブロ・ルンディア・エービーＧａｍｂｒｏ Ｌｕｎｄｉａ Ａｂ 透析酸前駆組成物
KR101813740B1 (ko) * 2010-06-23 2017-12-29 감브로 룬디아 아베 투석 전구체 조성물
PL2720678T3 (pl) * 2011-06-20 2021-05-04 Gambro Lundia Ab Kompozycja prekursorowa do dializy
WO2012175353A1 (fr) * 2011-06-20 2012-12-27 Gambro Lundia Ab Composition précurseur de dialyse
DE102011106248A1 (de) * 2011-07-01 2013-01-03 Fresenius Medical Care Deutschland Gmbh Behälter, Verwendung, Dialysegerät oder Zubereitungseinheit sowie Verfahren zur Herstellung eines Konzentrats
SE536913C2 (sv) * 2012-03-08 2014-10-28 Gambro Lundia Ab Komposition för dialys

Also Published As

Publication number Publication date
CN104159579B (zh) 2017-06-30
US9452149B2 (en) 2016-09-27
KR102062932B1 (ko) 2020-01-06
CN104159579A (zh) 2014-11-19
EP4223290A1 (fr) 2023-08-09
US20160354311A1 (en) 2016-12-08
CA2865315A1 (fr) 2013-09-12
AU2013201615B2 (en) 2015-02-19
US9724298B2 (en) 2017-08-08
KR20140132006A (ko) 2014-11-14
JP6125545B2 (ja) 2017-05-10
WO2013131906A1 (fr) 2013-09-12
AU2013201615A1 (en) 2013-09-26
SE536913C2 (sv) 2014-10-28
EP2822549B1 (fr) 2023-05-24
US20150024068A1 (en) 2015-01-22
EP2822549A1 (fr) 2015-01-14
SE1250217A1 (sv) 2013-09-09
JP2015509514A (ja) 2015-03-30
CA2865315C (fr) 2020-06-09

Similar Documents

Publication Publication Date Title
JOP20180102B1 (ar) مركب صيدلاني
JO3343B1 (ar) أحماض 5- أمينوتتراهيدروكوينولين-2- كربوكسيليك جديدة واستخدامها
MY172578A (en) Oral dosing of glp-1 compounds
MX2012015188A (es) Composiciones de liberacion controlada con efecto de alimentos reducido.
NZ628294A (en) Compositions and methods of use of phorbol esters for the treatment of stroke
MX2021004211A (es) Composiciones vacuna.
CR20140594A (es) Composiciones farmacéuticas y tratamiento de mastitis
AU342358S (en) Dental bite block
IN2014DN07326A (fr)
MX345926B (es) Nuevas composiciones, producción de las mismas y uso de las mismas para la producción de poliamidas coladas.
IN2014DN11078A (fr)
MX2013013649A (es) Compuestos de quinona para tratar enfermedades mediadas por ape1.
IN2014DN06738A (fr)
PH12015501099A1 (en) Synbiotic composition and use thereof
MX359181B (es) Hidrolizado de colágeno y uso del mismo.
HK1212166A1 (en) Citrate rich calcium magnesium supplement and uses thereof
IN2014MN01733A (fr)
MY165088A (en) Pharmaceutical compositions comprising alisporivir
UA117567C2 (uk) Композиція, яка стимулює лактацію, на основі фосфатидилсерину
MX2015001648A (es) Composiciones que comprenden derivados de espicamicina y metodos de uso de los mismos.
IN2014MN01382A (fr)
MA40027A (fr) Composition pharmaceutique comprenant un bêta-2 agoniste et un agent anticholinergique
IN2012DE00826A (fr)
PH12015501147A1 (en) Synbiotic composition and use thereof
MX2015008947A (es) Nuevas composiciones antifungicas.